Quarterly ResultAug 7, 2026, 08:11 AM
Clover Health Swings to Profit in Q2 2026; Revenue Up 55.6%
AI Summary
Clover Health Investments, Corp. reported a significant financial turnaround for Q2 2026, achieving a net income of $28.0 million compared to a net loss of $10.6 million in Q2 2025. Total revenues surged by 55.6% to $743.2 million. For the six months ended June 30, 2026, the company also posted a net income of $55.3 million, a substantial improvement from a $11.9 million net loss in the prior year period. The company also highlighted the strategic launch of Counterpart Health, Inc. in 2024, aiming to expand its Clover Assistant technology to external payors and providers.
Key Highlights
- Net income for Q2 2026 was $28.0 million, up from a $10.6 million net loss in Q2 2025.
- Total revenues for Q2 2026 increased 55.6% to $743.2 million from $477.6 million YoY.
- Net income for the six months ended June 30, 2026, was $55.3 million.
- Cash and cash equivalents rose to $198.8 million at June 30, 2026, from $78.3 million.
- Net cash provided by operating activities was $133.1 million for the six months.
- Launched Counterpart Health, Inc. to offer Clover Assistant technology externally.
Price Impact
More from CLOV